← All candidates
13 insider buys in the last year — $2.03M in all.
64 filings on record.
CTEVClaritev Corp
NYSE · Healthcare · $602.31M
$35.54
-2.47% · Sep 15
13 insider buys in the last year — $2.03M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 13 buys● 7 sells◆ 8 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what CTEV ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$602.31M
Float
5.6M
33% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
4.8
Price / sales
0.6
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
EVP, Chief Digital Officer
Kim Michael
Bought $429.0K on Feb 27 — 30,000 sh @ $14.30, held direct, 22% of their stake.
0 of 1 position beat the S&P
EVP, Chief Operating Officer
Hogge Jerome
Bought $300.8K on Aug 7 — 5,621 sh @ $53.51, held direct, 6.2% of their stake.
0 of 1 position beat the S&P
Pres., CEO & Executive Chair
Dalton Travis
Bought $249.8K on Nov 20 — 5,290 sh @ $47.23, held indirect, 55% of their stake.
1 of 2 positions beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
59 more transactions on Pro →Context
Wall St
$36.83 avg target
+3.6% vs today · 6 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 4 quarters beat
Q1 '26−$3.30 act−$4.68
Q4 '25−$3.19 act−$4.04
Q3 '25−$4.23 act−$0.68
Q2 '25−$3.81 act+$0.02
Coverage
Claritev Q1 Earnings Call HighlightsMarketBeat · 05-09Claritev Corporation Q1 2026 Earnings Call SummaryMoby · 05-07Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue EstimatesZacks · 05-07How The Claritev (CTEV) Story Is Shifting As Analysts Trim Targets Yet Stay PositiveSimply Wall St. · 05-05
The file stays open
64 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice